ATE343001T1 - Das parkin-protein als ubiquitinligase - Google Patents

Das parkin-protein als ubiquitinligase

Info

Publication number
ATE343001T1
ATE343001T1 AT01906293T AT01906293T ATE343001T1 AT E343001 T1 ATE343001 T1 AT E343001T1 AT 01906293 T AT01906293 T AT 01906293T AT 01906293 T AT01906293 T AT 01906293T AT E343001 T1 ATE343001 T1 AT E343001T1
Authority
AT
Austria
Prior art keywords
ubiquitin ligase
parkin protein
parkin
protein
image
Prior art date
Application number
AT01906293T
Other languages
English (en)
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE343001T1 publication Critical patent/ATE343001T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Noodles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
AT01906293T 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase ATE343001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000047801 2000-02-24

Publications (1)

Publication Number Publication Date
ATE343001T1 true ATE343001T1 (de) 2006-11-15

Family

ID=18569991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906293T ATE343001T1 (de) 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase

Country Status (10)

Country Link
US (1) US20050042607A1 (de)
EP (1) EP1262557B1 (de)
AT (1) ATE343001T1 (de)
AU (1) AU2001234171A1 (de)
CA (1) CA2398703A1 (de)
DE (1) DE60123934T2 (de)
DK (1) DK1262557T3 (de)
ES (1) ES2272444T3 (de)
MX (1) MXPA02008256A (de)
WO (1) WO2001062957A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017348B1 (en) * 2005-12-12 2011-09-13 Elan Pharma International Limited Assay for Parkinson's Disease therapeutics
CA2632657A1 (en) * 2005-12-12 2007-08-09 Elan Pharmaceuticals, Inc. Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929417T2 (de) * 1998-02-09 2006-08-03 Boehringer Ingelheim International Gmbh Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
GB9826276D0 (en) * 1998-12-01 1999-01-20 Univ Leeds Therapeutic agents for use in degenerative disorders
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein

Also Published As

Publication number Publication date
DE60123934T2 (de) 2007-10-18
DK1262557T3 (da) 2006-11-13
EP1262557B1 (de) 2006-10-18
WO2001062957A1 (fr) 2001-08-30
EP1262557A4 (de) 2003-05-02
AU2001234171A1 (en) 2001-09-03
US20050042607A1 (en) 2005-02-24
ES2272444T3 (es) 2007-05-01
CA2398703A1 (en) 2001-08-30
MXPA02008256A (es) 2003-01-28
EP1262557A1 (de) 2002-12-04
DE60123934D1 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
NO913524D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
ITPD990279A0 (it) Treppiede perfezionato, in particolare per impieghi ottici e fotografi ci.
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DE60207160D1 (de) Entwickungseinheit, Prozesskartusche und Bildaufzeichungsmethode
DE60233539D1 (de) Optisches Informationsaufzeichnungsmedium, Informationsaufzeichnungsverfahren, und dieses Aufzeichnungsmedium benutzendes Gerät
NL1022018A1 (nl) Belichtingswerkwijze.
DE60216538D1 (de) Toner, Entwickler und Bildaufzeichnungsverfahren
DE69931201D1 (de) Photoresist copolymer.
ATE306361T1 (de) Tragbares kraftwerkzeug
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
DE60123934D1 (de) Das parkin-protein als ubiquitinligase
DE60208598D1 (de) Toner, Bildherstellungsverfahren und Prozesskassette
ATE332807T1 (de) Infrarotempfindliche photoempfindliche zusammensetzung
BR0106896B1 (pt) aparelho de projeção centrìfuga.
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
ATE387455T1 (de) C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva
ATE320496T1 (de) Testisspezifische, menschliche proteinase, svph1- 8
NL1024693A1 (nl) Lichtontvangend apparaat, lichtdetectie apparaat, en een optisch signaal reproducerend apparaat.
藤原義弘 Influence of bacterial endosymbionts on host distributions in deep-sea chemosynthetic ecosystems
Sakamoto Toward an Accessible City for Every Person (Part 2)—The Pedestrian Bridges and the Parks—
ES1046749Y (es) Foco empotrable perfeccionado.
ES1046632Y (es) Foco perfeccionado.
ITVC980010A0 (it) Brill speciale multiuso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1262557

Country of ref document: EP

REN Ceased due to non-payment of the annual fee